疑似千里光类药物致药物性肝损伤1例分析

doi:10.19803/j.1672-8629.20220668

摘要/Abstract

摘要： 目的分析千里光类药物与药物性肝损伤的关系,为临床用药安全提供参考。方法对1例服用可疑千里光类药物后导致肝窦阻塞综合征患者进行分析;比对千里光碱（一种吡咯生物碱）标准品与患者血液、尿液样本色谱图,根据因果关系评价表（roussel uclaf causality assessment method, RUCAM）和《中草药相关肝损伤临床诊疗指南》分析评估可疑药物与肝损伤的相关性。结果该患者肝损伤表现为肝窦阻塞综合征,患者尿样本中可能存在千里光碱的类似物或代谢物,RUCAM量表评分为8分,判断可疑服用药物与肝损伤存在相关性。结论服用中药时,慎重评估有无千里光类药物成分,出现肝损伤时,应及时停药并进行针对性检查和治疗。

关键词: 千里光, 吡咯生物碱, 肝窦阻塞综合征, 药物性肝损伤, RUCAM量表, 药品不良反应

Abstract: Objective To analyze the relationship between Senecio scandens and drug induced liver injury, so as to provide reference for clinical safe drug use. Methods A case of hepatic sinusoidal obstruction syndrome after taking suspected senecio herb was reported. The chromatograms of the standard senecilline, which is one kind of Pyrrolizidine Alkaloids, with the patient’s blood and urine samples were compared, and the correlation between the suspected drug and liver injury was assessed according to the Roussel Uclaf Causality Assessment Method(RUCAM) and guidelines for clinical diagnosis and treatment of herb-induced liver injury. Results The patient’s liver injury was manifested as hepatic sinusoidal obstruction syndrome. The patient’s urine sample propably contained the analogues or metabolites of senecilline. The RUCAM scale score was eight points, judging that there was a correlation between suspected herbal medicine and liver injury. Conclusion When taking traditional Chinese medicine, carefully evaluate whether there are Senecio scandens. If liver injury occurs, the drug should be discontinued promptly and targeted investigations and treatment should be carried out.

Key words: Senecio scandens, pyrrolizidine alkaloids, hepatic sinusoidal obstruction syndrome, drug induced liver injury, RUCAM, adverse drug reaction

中图分类号:

R961
R994.11

于洁, 朱浩翔, 张继明. 疑似千里光类药物致药物性肝损伤1例分析[J]. 中国药物警戒, 2023, 20(2): 136-139.

YU Jie, ZHU Haoxiang, ZHANG Jiming. A case of suspected drug induced liver injury caused by Senecio Scandens[J]. Chinese Journal of Pharmacovigilance, 2023, 20(2): 136-139.

参考文献

[1] Cooperative Group for Hepatic and Gall Diseases. Expert consensus on diagnosis and treatment of pyrrolidine alkaloids - related sinusoidal obstruction syndrome (2017,Nanjing)[J]. Journal of Clinical Hepatology(临床肝胆病杂志), 2017, 33(9): 1627-1637.
[2] YU LC, MAO YM, CHEN CW.Guidelines for diagnosis and treatment of drug-induced liver injury[J]. Journal of Clinical Hepatology(临床肝胆病杂志), 2015, 31(11): 1752-1769.
[3] Branch of Hepatobiliary Diseases China Association of Chinese Medicine, Branch of Chinese Patent Medicine China Association of Chinese Medicine. Guideline for diagnosis and treatment of herb-induced liver injury[J]. Journal of Clinical Hepatology(临床肝胆病杂志), 2016, 32(5): 835-843.
[4] YIN LS, LI XY, SUN R.Analysis of the causes of senecio scandens clinical adverse reactions[J]. Chinese Journal of Pharmacovigilance(中国药物警戒), 2015, 12(3): 160-163.
[5] FENG Q, LI XY, SUN R.Advance research on pharmacological effect and toxicity of senecio scandens[J]. Chinese Journal of Pharmacovigilance(中国药物警戒), 2014, 11(3): 151-153.
[6] ZHU CK, ZHANG F, ZHUGE YZ, et al.Clinical characteristics of 115 cases of gynura segetum induced hepatic sinusoidal obstruction syndrome[J]. Chinese Journal of Digestion(中华消化杂志), 2017, 37(7): 448-452.
[7] YAKUSHIJIN K, ATSUTA Y, DOKI N, et al.Sinusoidal obstruction syndrome after allogeneic hematopoietic stem cell transplantation: Incidence, risk factors and outcomes[J]. Bone Marrow Transplant, 2016, 51(3): 403-409.
[8] LIU F, CAO X, YE J, et al.Oxaliplatin-induced hepatic sinusoidal obstruction syndrome in a patient with gastric cancer: a case report[J]. Mol Clin Oncol, 2018, 8(3): 453-456.
[9] SHEN T, FENG XW, GENG L, et al.Reversible sinusoidal obstruction syndrome associated with tacrolimus following liver transplantation[J]. World J Gastroenterol, 2015, 21(20): 6422-6426.
[10] ZHUGE YZ, WANG Y, ZHANG F, et al.Clinical characteristics and treatment of pyrrolizidine alkaloid-related hepatic vein occlusive disease[J]. Liver Int, 2018, 38(10): 1867-1874.
[11] WANG JY, GAO H.Tusanqi and hepatic sinusoidal obstruction syndrome[J]. J Dig Dis, 2014, 15(3): 105-107.
[12] LIN G, WANG JY, LI N, et al.Hepatic sinusoidal obstruction syndrome associated with consumption of Gynura segetum[J]. J Hepatol, 2011, 54(4): 666-673.
[13] YANG XQ, YE J, LI X, et al.Pyrrolizidine alkaloids-induced hepatic sinusoidal obstruction syndrome: pathogenesis, clinical manifestations, diagnosis, treatment, and outcomes[J]. World J Gastroenterol, 2019, 25(28): 3753-3763.
[14] MOHTY M, MALARD F, ABECASSIS M, et al.Sinusoidal obstruction syndrome/veno-occlusive disease: Current situation and perspectives-a position statement from the European Society for Blood and Marrow Transplantation (EBMT)[J]. Bone Marrow Transplant, 2015, 50(6): 781-789.
[15] ZHANG YT, LI S, ZHOU DH, et al.Clinical features of sinusoidal obstruction syndrome: an analysis of 35 cases and literature review[J]. Journal of Clinical Hepatology(临床肝胆病杂志), 2013, 29(12): 936-939.
[16] ZHU H, CHU Y, HUO J, et al.Effect of prednisone on transforming growth factor-β1, connective tissue growth factor, nuclear factor-κBp65 and tumor necrosis factor-α expression in a murine model of hepatic sinusoidal obstruction syndrome induced by Gynura segetum[J]. Hepatol Res, 2011, 41(8): 795-803.
[17] VALLA DC.Budd-Chiari syndrome and veno-occlusive disease/sinusoidal obstruction syndrome[J]. Gut, 2008, 57(10): 1469-1478.
[18] DIGNAN FL, WYNN RF, HADZIC N, et al.BCSH/BSBMT guideline: diagnosis and management of veno-occlusive disease (sinusoidal obstruction syndrome) following haematopoietic stem cell transplantation[J]. Br J Haematol, 2013, 163(4): 444-457.
[19] ZHU L, ZHANG CY, LI DP, et al.Tu-San-Qi (Gynura japonica): the culprit behind pyrrolizidine alkaloid-induced liver injury in China[J]. Acta Pharmacol Sin, 2021, 42(8): 1212-1222.
[20] KAKAR F, AKBARIAN Z, LESLIE T, et al.An outbreak of hepatic veno-occlusive disease in western Afghanistan associated with exposure to wheat flour contaminated with pyrrolizidine alkaloids[J]. J Toxicol, 2010(7980): 313280.
[21] EDGAR JA, SMITH LW.Transfer of pyrrolizidine alkaloids into eggs: food safety implications[J]. ACS Symp Ser, 1999, 745: 118-128.
[22] KEMPF M, HEIL S, HASSLAUER I, et al.Pyrrolizidine alkaloids in pollen and pollen products[J]. Mol Nutr Food Res, 2010, 54(2): 292-300.
[23] PANTER KE, JAMES LF.Natural plant toxicants in milk: a review[J]. J Anim Sci, 1990, 68(3): 892-904.